NPPA Asks Medtechs To Submit Data Of All 19 Devices Notified As Drugs On Prescribed Format To Prevent Overcharging
In order to monitor the price movement of medical devices notified as drugs under the Drugs and Cosmetics Act and to prevent the overcharging of these devices by the medical devices companies, the National Pharmaceutical Pricing Authority (NPPA) has asked all the medical device associations and manufacturers/importers /marketers to submit data as per the prescribed format in respect of all the 19 medical devices irrespective of their classification by May 31, 2017.
To monitor the price movement of 19 medical devices out of 23 medical devices notified as drugs under the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945, the NPPA had earlier developed a format and the same was shared with the medical devices industries and associations for their comments/views. A series of meetings were held with the medical devices industries and associations for the purpose of arriving at a consensus on the format which will be used for collecting data on medical devices for monitoring.
To monitor the price movement of 19 medical devices out of 23 medical devices notified as drugs under the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945, the NPPA had earlier developed a format and the same was shared with the medical devices industries and associations for their comments/views. A series of meetings were held with the medical devices industries and associations for the purpose of arriving at a consensus on the format which will be used for collecting data on medical devices for monitoring.